The role of calcineurin in amyloid-beta-peptides-mediated cell death

Brain Res. 2005 Jul 19;1050(1-2):1-7. doi: 10.1016/j.brainres.2005.04.078.

Abstract

Amyloid beta-peptide (Abeta) is widely held to be associated with Alzheimer's disease. It was previously demonstrated by our group that Abeta induces cell death by an apoptotic process. We report here that activation of the caspase-3 apoptotic cascade is regulated by calcineurin-mediated BAD dephosphorylation. Calcineurin inhibitors were also proven to be effective by preventing the loss of mitochondrial membrane potential (Delta Psim) induced by Abeta, not allowing cytochrome c release from mitochondria and subsequently caspase-3 activation. Considering the results presented, we argue that calcineurin activation and BAD dephosphorylation are upstream in premitochondrial signaling events leading to caspase-3 activation in Abeta-peptide-treated cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / pharmacology*
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Calcineurin / metabolism*
  • Calcineurin Inhibitors
  • Carrier Proteins / metabolism
  • Caspase 3
  • Caspases / metabolism
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cyclosporine / pharmacology
  • Drug Interactions
  • Electron Transport / drug effects
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Peptide Fragments / pharmacology*
  • Phosphorylation
  • Tacrolimus / pharmacology
  • Teratocarcinoma
  • bcl-Associated Death Protein

Substances

  • Amyloid beta-Peptides
  • BAD protein, human
  • Calcineurin Inhibitors
  • Carrier Proteins
  • Immunosuppressive Agents
  • Peptide Fragments
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (25-35)
  • amyloid beta-protein (35-25)
  • amyloid beta-protein (40-1)
  • bcl-Associated Death Protein
  • Cyclosporine
  • Calcineurin
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • Tacrolimus